ArticleLeukemia2025

CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents.

Tom Reuvekamp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.